Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
Operating income as a percentage of revenue
5Y CAGR
+25.1%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
3.1x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 14.02% | +57.1% |
| 2024 | 8.92% | +4.5% |
| 2023 | 8.54% | +299.0% |
| 2022 | -4.29% | -158.8% |
| 2021 | 7.29% | +59.4% |
| 2020 | 4.57% | +129.9% |
| 2019 | -15.29% | -1192.5% |
| 2018 | -1.18% | -105.0% |
| 2017 | 23.71% | -15.2% |
| 2016 | 27.98% | - |